The enhancing effects of lead acetate on the lethal and the bodyweight-decreasing activities of endotoxin in mice with different combinations of the administration routes.
SUMMARY:
The enhancing effects of lead acetate on the lethal and the bodyweight-decreasing activities of endotoxin in mice with different combinations of the administration routes.
The effect of lead acetate on the lethality was shown by iv administration, but not by ip administration. The body-weight-decreasing activity of endotoxin was enhanced by ip administration of lead acetate but not by iv administration.
In any case, the route of administration of endotoxin was not concerned with the enhancement by lead acetate. Selye et al. (1966) found the enhancing effect of lead acetate on the lethal activity of endotoxin by iv administrations of both in the rat. Truscott (1969) reported that the enhancing effect of lead acetate on the lethal activity of endotoxin in chicks was shown by iv administrations of lead acetate, but not by the ip administration. Similar results were also obtained in mice (Terao and Katsuno, 1978) . Thus, it is suggested that it may be important to give lead acetate intravenously for the enhancement of endotoxin lethality. While, we have demonstrated in mice that lead acetate administered intraperitoneally enhanced the body-weight-decreasing activity of endotoxin given by the same route (Kuratsuka and Fujiwara, 1972, 1974; Fujiwara and Kuratsuka, 1978 , 1980 , 1982 . In mice, then, it is of interest to compare the enhancement of the lethal and the body-weight-decreasing activities of endotoxin by the combinations of the ip and iv administration routes of both substances.
A lipopolysaccharide (LPS) preparation (Control No. 613122, Difco, Detroit, MI) prepared by Westphal's method from Escherichia coli 0 111 B4 cells was used throughout as endotoxin. For the experiments of the lethal activity, 5 mg (ip) or 1 mg (iv) per mouse of lead acetate (Wako Junyaku, Osaka) was used. These doses were led from the data of LD5,o of lead acetate, 11.6 mg per mouse et KURATSUKA cantly enhanced by the ip administration of lead acetate. Now it was confirmed that the lead acetate administered intravenously showed no enhancing effect. No report other than ours (Fujiwara and Kuratsuka, 1978 , 1980 , 1982 Kuratsuka and Fujiwara, 1972, 1974) about the enhancing effect of lead acetate on the body-weight-decreasing activity of endotoxin in mice has appeared. In respect of the lethality, our results in this report agree well to those in the reports by other workers (Truscott, 1969; Terao and Katsuno, 1978) , though they did not make such many combinations of the administration routes as we did.
The relation between the enhancing effect and the route of administration of lead acetate on the lethal activity of endotoxin was opposite to that on the body-weight-decreasing activity. Such dissociation of the enhancing effects on the activities of endotoxin was demonstrated at least in mice. The fact must depend on the difference in the mode of action of the lethal and the body-weightdecreasing activities of endotoxin. Schaedler et al. (1961) suggested different mechanisms for the two activities and reported that the loss of body weight occurred even in mice which are remarkably resistant to the lethal effects of endotoxin. These findings suggest that lead acetate may serve as a useful tool for elucidating the two distinct activities of endotoxin.
